Butterfly Network Insider Sales Spike: CEO, CFO, and CTO Sell 12M Shares as Execs Cover Taxes and Watch Earnings Ahead

Insider Selling at Butterfly Network: What It Means for Investors

In the most recent Form 4 filing, CAO and SVP of Finance, Megan Carlson, sold 10,114 shares of Butterfly Network’s Class A common stock on 2026‑10‑02. The shares were sold at a weighted average price of $8.75, a price slightly below the current market level of $8.70. The sale was part of a “sell‑to‑cover” policy that covers the tax withholding obligations on newly vested restricted‑stock units. While the transaction itself is routine, the timing—just days before the company’s quarterly earnings report—is noteworthy, especially against a backdrop of heightened insider activity across the board.

Insider Activity in the Current Quarter

Butterfly Network has seen a flurry of insider sales in the last three months. CEO Joseph Devivo sold over 6 million shares between July and September, and other top executives—including CFO John Doherty and CTO Victor Ku—have each sold several hundred thousand shares. The cumulative volume of insider sales this quarter is more than 12 million shares, or roughly 0.5 % of the company’s outstanding shares. In a market that is already under pressure (the 52‑week low hit $1.90 last year and the current price sits at $9.38), such volume can amplify volatility.

The current sell‑to‑cover transaction is consistent with a pattern of periodic, modest‑sized sales that are largely driven by vesting and tax considerations rather than a wholesale divestment of equity. Investors should note, however, that the concentration of sales among senior executives could signal that the leadership is focused on cash‑flow management and may be less inclined to support aggressive growth initiatives in the near term.

What the Numbers Say About Butterfly’s Future

Butterfly Network’s financials paint a mixed picture. The company posted a negative price‑to‑earnings ratio of –30.14, reflecting its ongoing investment in R&D and market expansion. Its 52‑week high of $10.05 and current price of $9.38 show that the stock has recovered from last year’s trough, but the recent weekly decline of 4.4 % suggests that investors are still cautious. The short‑sale disclosures by Walleye Capital LLC indicate a modest but real short interest—just above 1 % of the company’s shares—adding another layer of pressure.

Given these dynamics, the insider selling is likely to be perceived as a normal tax‑cover activity rather than a red flag. However, the concentration of sales among top executives could lead market participants to scrutinize upcoming earnings and guidance more closely. If the company delivers on its AI‑driven imaging roadmap and secures additional regulatory approvals, the stock could rebound, offsetting the short‑term impact of insider selling.

Megan Carlson: A Profile of the Insider

Megan Carlson’s trading history shows a pattern of regular, incremental sales. Over the past year, her average sale price has ranged from $3.71 (March 2026) to $8.82 (October 2026), reflecting the natural increase in share value over time. She has sold between 41,000 and 110,000 shares in single transactions, typically during periods of vesting or tax withholding. Notably, her most recent sale in October represents a smaller fraction of her total holdings (401,971 shares post‑sale), suggesting a disciplined approach that balances liquidity needs with long‑term ownership.

Carlson’s trades are consistent with a conservative strategy: she sells just enough to cover tax obligations without dramatically diluting her stake. Her consistent adherence to the sell‑to‑cover policy indicates that she trusts the company’s long‑term prospects and is not seeking to exit early. For investors, this behavior can be seen as a positive signal that the leadership is not under immediate financial pressure, but rather is maintaining a stable equity position while managing tax liabilities.

Investor Takeaway

For investors in Butterfly Network, the current insider activity—especially the recent sell‑to‑cover transaction—should be viewed as routine rather than alarming. The broader pattern of executive sales, coupled with a modest short interest, suggests that the market is still evaluating the company’s growth trajectory amid a challenging healthcare tech landscape. Those looking for a long‑term bet on Butterfly’s AI‑driven imaging technology may view the current price dip as a buying opportunity, provided the company continues to advance its product pipeline and achieve operational profitability.